Hepatitis Weekly articles from April 2004

Hepatitis Weekly archives from April 2004

Pioglitazone prevents hepatic steatosis in animal models.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pioglitazone prevents hepatic steatosis in animal models. According to a study from Japan, "non-alcoholic steatohepatitis (NASH) may progress to liver cirrhosis, and NASH patients with liver...

A critical juncture for hemodialysis-related HCV passage is saline flushing.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A critical juncture for hemodialysis-related HCV passage is saline flushing. According to recent research published in the International Journal of Artificial Organs, "the hepatitis C virus is a...

The ribavirin prodrug viramidine has proven safe in healthy volunteers.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The ribavirin prodrug viramidine has proven safe in healthy volunteers. "Ribavirin, part of the current first-line combination therapy for the treatment of chronic hepatitis C, has side effects - in...

Non-radioactive labeled hepatitis B virus probes are sensitive and inexpensive.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Non-radioactive labeled hepatitis B virus probes are sensitive and inexpensive. "A method using non-radioactive material alkaline phosphatase to label HBV DNA as probe has been studied and used in...

Microarray distinguishes the molecular signatures of hepatocellular carcinomas.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Microarray distinguishes the molecular signatures of hepatocellular carcinomas. According to a study from Japan, "chronic infection with hepatitis B or C virus (HBV or HCV) is the most clearly...

Hepatitis delta virus probably harbors at least seven major clades.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Hepatitis delta virus probably harbors at least seven major clades. "Hepatitis D virus (HDV) is a satellite of hepatitis B virus (HBV) for transmission and propagation and infects nearly 20 million...

Lamivudine helps keep HBV at bay during cancer chemotherapy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers in Hong Kong have discovered a way to help prevent the reactivation of the hepatitis B virus (HBV) in women who are being treated with chemotherapy for breast cancer. Winnie Yeo, an...

Hepatitis B core antigen makes T cells and monocytes secrete interleukin-10.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Hepatitis B core antigen makes T cells and monocytes secrete interleukin-10. "In chronic hepatitis B virus (HBV) infection, immune responses to hepatitis B core antigen (HBcAg) are weak. Interleukin...

Brain dysfunction in some cirrhotic patients impairs driving ability.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Brain dysfunction that sometimes develops in patients with cirrhosis can impair driving ability, according to the results of a prospective controlled study recently conducted by researchers in Germany....

New avidin-biotin complexes may carry oligo-DNA to the liver.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- New avidin-biotin complexes may carry oligo-DNA to the liver. "To establish an effective nonviral gene transfer vector to hepatocytes, various oligo-carrier complexes were developed employing...

Impact of HCV coinfection on risk of HAART-induced liver damage reviewed.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The impact of HCV infection on the risk of HAART-induced liver damage has been reviewed. "Drug-induced liver injury (DILI) is the elevation of liver enzyme and/or bilirubin levels caused by the use...

IFN-alpha with ribavirin can suppress virus-specific immunity.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Treatment with interferon (IFN)-alpha and ribavirin may impair immune responses to non-HCV viruses. Anti-HCV treatment "combining IFN-alpha and ribavirin (IFN+R) has still poorly defined effects on...

Hepatitis A peptide covalently linked to liposomes.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A hepatitis A peptide has been covalently linked to liposomes. "In this work we have studied the conjugation of the immunogenic peptide sequence (110-121) belonging to the VP3 capsid protein of...

Bacteriophage-mediated nucleic acid immunization offers benefits.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Bacteriophage-mediated nucleic acid immunization offers benefits over naked DNA vaccines. "Whole bacteriophage lambda particles, containing reporter genes under the control of the cytomegalovirus...

Self-reported hepatitis B vaccination status unreliable among drug users.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Self-reported hepatitis B virus infection and vaccination status among young drug users is unreliable. "Self-reported hepatitis B virus (HBV) infection status and immunization status were compared...

Infection rate in a Midwestern community is dependent on the country of origin.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A new study has examined the prevalence of the hepatitis B virus (HBV) in a small Midwestern population and found that immigrants from HBV-endemic parts of the world made up the majority of cases. ...

Nabi to supply Novaplus Nabi-HB.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NABI) has signed an agreement with Novation, LLC, to supply Nabi-HB, [Hepatitis B Immune Globulin (Human)] through Novation's Novaplus Private Label Program. Novaplus, the...

Newly identified pathways reveal molecules that effect HBV inhibition.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Newly identified pathways reveal molecules that effect HBV inhibition. "The replication of hepatitis B virus (HBV) in hepatocytes is strongly inhibited in response to interferon (IFN)-alpha/beta and...

Hepatitis C DNA vaccine induces strong DTH response in mice.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A hepatitis C virus core protein-expressing DNA vaccine induced a strong class I-binding peptide DTH response in mice. "The hepatitis C virus (HCV) core protein-encoding sequence (HCcAg) is the...

No "safe" level of alcohol use for patients with hepatitis C.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A number of studies have indicated that heavy alcohol consumption contributes to the progression of chronic hepatitis C virus (HCV); however, light alcohol intake has not been shown to have the same...

Uniquely tagged NS5B identifies specific inhibitors of HCV polymerase.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Uniquely tagged NS5B identifies specific inhibitors of HCV polymerase. According to published research from Canada, "the interaction of the hepatitis C virus (HCV) RNA-dependent RNA polymerase with...

Older age at acquisition makes viral hepatitis progress faster.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Older age at acquisition makes viral hepatitis progress faster. According to scientists writing in the journal Epidemiology and Infection, "we investigated whether there are differences between the...

Cavernous hemangiomas are smaller in patients with chronic liver disease.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Cavernous hemangiomas are smaller in patients with chronic liver disease. "The purpose of our study was to assess the difference in magnetic resonance imaging (MRI) features of cavernous hemangiomas...

Hepatitis C virus core protein thwarts effector cytotoxic T-cell differentiation.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus core protein thwarts effector cytotoxic T-cell differentiation. "In a companion study, we showed a dichotomy between the expansion of central memory (CCR7[superscript]+) hepatitis...

First patient accepted in phase III liver cancer study.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Delcath Systems, Inc., (DCTH) said the first patient has been accepted for enrollment in its phase III clinical trial for inoperable cancer in the liver. The patient will be treated at the Sydney...

Rare metastatic brain lesions can arise from hepatocellular carcinoma.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Rare metastatic brain lesions can arise from hepatocellular carcinoma. "Brain metastases from hepatocarcinoma (HCC) are exceptional and only a few cases have been reported in the literature, mainly...

Doctors call for balancing of patient/worker viral transmission protection.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Health care staff are at a much higher risk of acquiring viral infections from infected patients than vice versa. These viral infections include HIV and hepatitis. Despite this, patients receive...

Plasma exchange techniques temporarily support liver transplant candidates.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Plasma exchange techniques temporarily support liver transplant candidates. According to published research from the People's Republic of China, "to determine if plasma exchange combined with plasma...

Valaciclovir treats chronic hepatitis B after lung transplantation.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Valaciclovir treats chronic hepatitis B after lung transplantation. According to researchers in Switzerland, "we report on a chronic asymptomatic hepatitis B surface antigen (HBsAg) carrier who...

Serology used to determine prevalence of infection with waterborne pathogens.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Serology is an effective method of determining the prevalence of infection with waterborne pathogens in very young children. "Water and sanitation interventions in developing countries have...

South African duck hepatitis B virus isolates share Western signatures.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- South African duck hepatitis B virus isolates share Western signatures. According to recent research from South Africa, "the objective of the study was to characterize the genome of duck hepatitis B...

Chimpanzees permit hepatic quantification of hepatitis B virus cccDNa.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Chimpanzees permit hepatic quantification of hepatitis B virus cccDNa. "We have previously shown that hepatitis B virus (HBV) replication is controlled by noncytolytic mechanisms that depend...

Ion pockets on the HCV IRES IIId domain identify targets for inhibition.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Ion pockets on the HCV IRES IIId domain identify targets for inhibition. "The dynamic behavior of the HCV IRES IIId domain is analyzed by means of a 2.6-ns molecular dynamics simulation, starting...

Mutation disrupts interaction of von Willebrand factor with platelets.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- C1272S is a new candidate mutation in type 2A von Willebrand disease that disrupts the disulfide loop responsible for the interaction of von Willebrand factor with platelet GP Ib-IX. According to a...

Urinary nitrite/nitrate reveals the success of common hepatitis C therapy.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Urinary nitrite/nitrate reveals the success of common hepatitis C therapy. According to published research from Italy, "in this study we tried to elucidate the role of nitric oxide (NO) in chronic...

Lamivudine prevents hepatitis B virus reactivation in cancer patients.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Lamivudine prevents hepatitis B virus reactivation in cancer patients. "Although hepatitis B virus (HBV) reactivation in HBV carriers undergoing immunosuppressive therapy is clearly documented, the...

Liver transplantations are acceptable for disulfiram-linked liver failure.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Liver transplantations are acceptable for disulfiram-linked liver failure. According to recent research from the United States, "disulfiram has been used as a popular adjunct in programs for...

Age, sex, and fibrosis impact findings in chronic hepatitis C patients.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Age, sex, and fibrosis impact findings in chronic hepatitis C patients. According to published research from Japan, "in 504 patients with chronic hepatitis C who underwent liver biopsy, the...

Hepatitis C virus p7 protein is a potential target for antiviral therapy.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus p7 protein is a potential target for antiviral therapy. "We previously identified the function of the hepatitis C virus (HCV) p7 protein as an ion channel in artificial lipid...

Liver interferon 1 receptors predict response in chronic hepatitis C patients.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Liver interferon 1 receptors predict response in chronic hepatitis C patients. "The type I interferon (IFN) receptor consists of at least two subunits, IFNAR1 and IFNAR2. We previously found a...

Interferons used for treating multiple sclerosis raise liver enzyme levels.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Interferons used for treating multiple sclerosis raise liver enzyme levels. According to recent research from Canada, "a population-based retrospective chart review of the biochemical liver tests...

Biopharmaceutical reports increase in cash position and total shareholder equity.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., (HEB) announced results for its year ended December 31, 2003. The company reported a loss of $14,770,000, or $0.42 per share, compared to a loss of $7,424,000 or $0.23...

Therapeutics company earns milestone payment.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Valentis Inc. (VLTS) has earned a milestone payment from Genencor International, Inc. (GCOR), which resulted from Genencor's initiation of subject dosing in a phase I clinical trial of its DNA-based...

VScan maker agrees to production facility in China.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Medical Services International, Inc., (MSITF) has agreed to an assembly/production facility with a company based in Shanghai, People's Republic of China. The agreement is in the form of a joint...

Interferon improves survival in HCV patients by negating liver-related death.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Interferon improves survival in HCV patients by negating liver-related death. According to recent research from Japan, "interferon therapy for chronic hepatitis C reduces the risk of hepatocellular...

Jerini enters agreement for Icatibant production.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Jerini, AG, and Bachem, AG, announced a collaboration agreement for production and supply of Jerini's lead compound Icatibant. At present, Icatibant is being tested in several clinical trials to...

Company announces U.S. launch of liver fibrosis assay HCV FibroSURE.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Laboratory Corp. of America Holdings (LabCorp) (LH) announced the availability of HCV FibroSURE, a noninvasive blood test for assessing liver status in hepatitis C virus (HCV) patients. Developed...

Diagnostics company announces test and technology acquisitions.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Rapid Bio Tests Corporation (RBIO) has entered into an agreement with Dr. Michael Huchital of Warwick, New York, in which Rapid Bio Tests will acquire by way of a formal asset purchase agreement, all...

Prescription requirement for OTC medicines aimed to help Nez Perce tribe.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Nez Perce tribal members must now have prescriptions for over-the-counter medications. The Nimiipuu Health Board recently approved the policy change at the recommendation of tribal healthcare...

Treatment for HBV infection in HIV patients reviewed.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- The treatment guidelines for patients infected with HIV and HBV have been reviewed. "Among human immunodeficiency virus (HIV)-infected individuals, the prevalence of hepatitis B surface antigen...

Hepatitis C antibody marks drug response in patients with aplastic anemia.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hepatitis C antibody marks drug response in patients with aplastic anemia. "Immunosuppression (IS) therapy with antilymphocyte globulin (ALG) is currently the treatment of choice for patients with...

Ribozyme package effective against virus in liver.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Penn State College of Medicine researchers have developed a tiny package that searches for and destroys up to 80% of hepatitis B virus in the livers of mice. "This marks one of the few successful...

High-dose interferon treats acute hepatitis C regardless of receptor levels.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- High-dose interferon treats acute hepatitis C regardless of receptor levels. According to recent research published in the journal Digestive Diseases and Sciences, "efficacy of interferon (IFN)...

The Fas ligand system is significant to chronic hepatitis B-linked liver injury.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- The Fas ligand system is significant to chronic hepatitis B-linked liver injury. According to a study from South Korea, "cytotoxic T lymphocytes are essential components of immune responses during...

Hemispherx completes acquisition for worldwide rights to Alferon N.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., (HEB) announced that it has completed the second and final agreement with Interferon Sciences (ISI), including the acquisition of all the worldwide rights on Alferon N as...

Hepatitis C patients are at risk of late, rapid post-SCT cirrhosis.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hepatitis C patients who undergo stem-cell transplantation have a heightened risk of rapid cirrhosis development for years to come. "Chronic hepatitis C is often asymptomatic, at least during the...

Hepatitis C virus variants may not associate with extent of pathogenesis.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus variants may not associate with extent of pathogenesis. "Variants of hepatitis C virus (HCV) from a single infected blood donor and 13 viremic recipients who were traced were...

Hepatitis B virus genotype C bears two major subgroups.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hepatitis B virus genotype C bears two major subgroups. "A genomic characterization of hepatitis B virus (HBV) was done for 56 pre-S1/pre-S2 genes and 10 full-length HBV genotype C isolates from...

HCV superinfections have differential effects on HBV-related cirrhosis.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- HCV superinfections have differential effects on HBV-related cirrhosis. "We investigated the virological impact of acute hepatitis C virus (HCV) superinfection on two patients with hepatitis B...

Hepatitis B virus DNA in culture can be analyzed for life cycle dynamics.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hepatitis B virus DNA in culture can be analyzed for life cycle dynamics. According to a study from the People's Republic of China, "the 2.2.15 cells-derived from HepG2 cells transfected with a...

Hepatitis C virus RNA replication shows specificity for intracellular sites.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- Hepatitis C virus RNA replication shows specificity for intracellular sites. "Biochemical studies revealed that nonstructural proteins of hepatitis C virus (HCV) interacted with each other and were...

New models offer long-term prognoses for patients with hepatitis C infections.
April 12, 2004... 2004 APR 12 - (NewsRx.com & NewsRx.net) -- New models offer long-term prognoses for patients with hepatitis C infections. "Obtaining unbiased estimates of HCV prognosis is difficult because of potential biases associated with study design...

Forty-eight weeks of therapy may not be long enough for treating HCV type 1.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Forty-eight weeks of therapy may not be long enough for treating HCV type 1. According to recent research published in the Journal of Infectious Diseases, "the therapeutic response among patients...

A new immunoassay monitors HCV-infected patients for treatment response.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- A new immunoassay monitors HCV-infected patients for treatment response. According to recent research from Egypt, "hepatitis C virus (HCV) infection continues to be an emerging global health...

Flutamide produces liver toxicity and a death in Germany.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Flutamide produces liver toxicity and a death in Germany. "Flutamide is an antiandrogen and frequently used for the treatment of prostatic cancer. Severe hepatotoxicity occurs in few patients but...

Highly specific probes detect hepatitis C virus in liver tissues.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Highly specific probes detect hepatitis C virus in liver tissues. "Although recent studies have analyzed hepatitis C (HCV) infections in liver tissue by in situ hybridization (ISH), many of these...

Methylated p16 may be a tumor marker for hepatocellular carcinoma.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Methylated p16 may be a tumor marker for hepatocellular carcinoma. According to a study from South Korea, "hepatocellular carcinomas (HCCs) show genomic alterations, including DNA rearrangements...

Human leukocyte antigen alleles link hepatitis C virus to liver cancer.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Human leukocyte antigen alleles link hepatitis C virus to liver cancer. "Our aim was to investigate whether different human leukocyte antigen (HLA) genes might be associated with hepatitis C virus...

Contrast agent concentration in mouse blood used to determine tumor vascularity.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Contrast agent concentration in mouse blood in vivo is useful for the determination of tumor vascularity. "A method for measuring contrast agent concentration in blood was developed using a...

Sinusoidal capillarization is distinct from angiogenesis in benign liver tumors.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Sinusoidal capillarization is distinct from angiogenesis in benign liver tumors. "To better understand how benign hepatocellular tumors acquire nutrient vessels, we investigated the...

Genomics company "sharpens" focus, announces layoffs; CEO to retire.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced it is sharpening its focus in preparation for the commercialization of the company's most promising drug candidates. As part of this strategy, the...

Multimodality therapy for rectal cancer led to massive iliac artery bleeding.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Multimodality therapy for advanced rectal cancer led to massive iliac artery bleeding in two patients. "Multimodality treatment for advanced rectal cancer, including intraoperative radiation...

Liver graft failure occurs despite antiviral prophylaxis.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Liver graft failure occurs despite antiviral prophylaxis. According to a study from Japan, "recurrence of hepatitis C virus after liver transplantation is common and cholestatic hepatitis occurs...

Interferon therapy restrains wild-type and precore mutated HBV equally.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Interferon therapy restrains wild-type and precore mutated HBV equally. "Interferon (IFN) alfa-2a was administered to 23 patients with chronic hepatitis B daily for 4 weeks and the relation between...

Methods for HAV detection in shellfish compared.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- The merits and drawbacks of different techniques for detecting HAV contamination in shellfish have been determined. "The detection of hepatitis A virus (HAV) in shellfish by reverse...

Altered caveolin and thrombospondin reveal liver cancer vessel status.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Altered caveolin and thrombospondin reveal liver cancer vessel status. According to a study from the United States, "macroregenerative and dysplastic nodules (MDNs) are hepatocellular carcinoma...

At-Home hepatitis C, instant cholesterol, allergen, and HIV test announced.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Vencor International, Inc., (VNCO), announced that it is initiating the distribution of U.S. Food and Drug Administration (FDA)-approved at-home tests for HIV and other diseases and conditions...

Undetectable HCV viremia and normal liver enzyme levels may not mark cure.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Undetectable HCV viremia and normal liver enzyme levels may not be a guarantee of hepatitis C resolution in HIV patients. According to published research from Canada, "[i]ndividuals with positive...

Repeat hepatectomy for recurring metastasis confers survival benefits.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Repeat hepatectomy for recurring metastasis confers survival benefits if tumorous masses are completely removed. "Although in recent years hepatic resection has become a safe procedure, there are...

Injured liver cells signal fibrosis in nonalcoholic fatty liver disease.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Injured liver cells signal fibrosis in nonalcoholic fatty liver disease. According to a study from the United States, "nonalcoholic fatty liver disease (NAFLD) represents a spectrum of...

Ticlopidine-induced cholestatic hepatitis diminishes slowly.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Ticlopidine-induced cholestatic hepatitis diminishes slowly. According to researchers in Italy, "we report a case of ticlopidine-induced cholestasis in a 62-year-old man with no previous...

Octreotide regulates CC-induced chemokine production in rat Kupffer cells.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Octreotide regulates CC-induced chemokine production in rat Kupffer cells. According to published research from Greece, "Kupffer cells (KC) and lipopolysaccharide (LPS) interaction is the initial...

Minimally invasive treatments effective as surgery for solitary tumors.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Results of a new study show that combining two minimally invasive interventional radiology treatments for liver cancer is as effective as surgery for treating single tumors up to 7 cm in diameter. ...

Phase I pharmacokinetic trial of orally dosed histamine completed.
April 19, 2004... 2004 APR 19 - (NewsRx.com & NewsRx.net) -- Maxim Pharmaceuticals (MAXM) has completed a phase Ia pharmacokinetic trial of a new orally dosed histamine dihydrochloride drug candidate. The normal-volunteer pharmacokinetic trial is intended to...